Product Information
Selective antagonist of α4β2 nicotinic acetylcholine receptors (nAChRs), selective over α4β4, α3β2, and α3β4α5 nAChRs. Lowers nicotine self-administration in vivo for 30 minutes. Inhibits nicotine seeking, following relapse, during both prime- and cue-induced reinstatement.
Chemical properties
Technical inquiry about: 3D-BA167283 AP 202
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.